Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
ht decrease » _ decrease (Expand Search), nn decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
16 we » 16 w (Expand Search), 1_ we (Expand Search)
5 ht » 5 h (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
ht decrease » _ decrease (Expand Search), nn decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
16 we » 16 w (Expand Search), 1_ we (Expand Search)
5 ht » 5 h (Expand Search)
-
81
-
82
-
83
-
84
-
85
-
86
Flow chart for the analysis of cardiovascular risk and depression in the PREDIMED-PLUS trial.
Published 2022Subjects: -
87
Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs
Published 2022“…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
-
88
Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs
Published 2022“…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
-
89
-
90
Statistical details of data presented in Fig 16.
Published 2024“…<div><p>The rapid decrease of light intensity is a potent stimulus of rats’ activity. …”
-
91
-
92
Pharmacokinetic models and concentrations predictions of treatments considered.
Published 2021Subjects: -
93
-
94
-
95
Overview of the WeARTolerance program.
Published 2024“…This research evaluates the "WeARTolerance’’ arts-based program in reducing mental health stigma among diverse youths. …”
-
96
-
97
-
98
-
99
-
100